Evaluating new CD4 enumeration technologies for resource-constrained countries

Nature Reviews Microbiology

Volumn 6, Issue SUPPL. 11, 2008, Pages

  Stevens, Wendy ^a   Gelman, Rebecca ^b   Glencross, Deborah K ^a   Scott, Lesley E ^a   Crowe, Suzanne M ^c   Spira, Thomas ^d  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c MONASH UNIVERSITY   (Australia)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANALYZER; ARTICLE; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; DEATH; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; GOOD LABORATORY PRACTICE; HEALTH CARE ACCESS; HEALTH CARE DELIVERY; HEALTH CARE QUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGICAL MONITORING; LABORATORY TEST; MEDICAL TECHNOLOGY; MORBIDITY; MORTALITY; PRIORITY JOURNAL; QUALITY CONTROL; REPRODUCIBILITY; SAFETY; SERODIAGNOSIS; TREATMENT FAILURE; VIRUS LOAD;

ADULT; ANTIVIRAL AGENTS; CD4 LYMPHOCYTE COUNT; DEVELOPING COUNTRIES; EVALUATION STUDIES AS TOPIC; FLOW CYTOMETRY; GUIDELINES AS TOPIC; HIV INFECTIONS; HUMANS; INFANT; QUALITY CONTROL; RESEARCH DESIGN;

EID: 54149090227     PISSN: 17401526     EISSN: None     Source Type: Journal    
DOI: 10.1038/nrmicro2000     Document Type: Article

References (69)

1. UNAIDS/WHO. AIDS epidemic update [online], http://data.unaids.org/ pub/EPISlides/2007/2007_epiupdate_en.pdf (UNAIDS/WHO, Geneva, Switzerland, 2007).
2. Plate, D. K. Evaluation and implementation of rapid HIV tests: The experience in 11 African countries. AIDS Res. Hum. Retroviruses 23, 1491-1498 (2007).
3. Peeling, R. W, Smith, P. G. & Bossuyt, P. M. A guide for diagnostic evaluations. Nature Rev. Microbiol. 4, S2-6 (2006).
4. Petti, C. A., Polage, C. R., Quinn, T. C., Ronald, A. R. & Sande, M. A. Laboratory medicine in Africa: A barrier to effective health care. Clin. Infect. Dis. 42, 377-382 (2006).
5. Glencross, D. K., Stevens, G., Scott, L. E., Mendelow, B. V. & Stevens, W. The challenge of laboratory monitoring of HIV. S. Afr. Med. J. 92, 248 (2002).
6. Glencross, D. K., Mendelow., B. V. & Stevens, W. S. Laboratory monitoring of HIV/AIDS in a resource-poor setting. S. Afr. Med. J. 93, 262-263 (2003).
7. Stevens, W. S. et al. Affordable HIV diagnosis and monitoring for scaling up ARV treatment programs. S. Afr. J. HIV Med. 20, 38-41 (2005).
8. + lymphocytes as prognostic markers of HIV-1 infection. Ann. Intern. Med. 126 946-954 (1997).
9. Fahey, J. L. et al. The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1. N. Engl. J. Med. 322, 166-172 (1990).
10. Panel on Antiretroviral Guidelines for Adults and Adolescents, Department of Health and Human Services. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents [online], http://www.aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf (Department of Health and Human Services, Washington, USA, 2008).
11. WHO. Patient monitoring guidelines for HIV care and antiretroviral therapy (ART) [online], http://www.who.int/entity/hiv/pub/guidelines/ patientmonitoring.pdf (WHO, Geneva, Switzerland, 2004).
12. Gazzard, B. British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy. HIV Med. 7 487-503 (2006).
13. Glencross, D. K., Scott, L. E., Jani, I. V., Barnett, D. & Janossy, G. CD45-assisted PanLeucogating for accurate, cost-effective dual-platform CD4+ T-cell enumeration. Cytometry 50, 69-77 (2002).
14. Mandy, F. F., Bergeron, M. & Minkus, T. Evolution of leukocyte immunophenotyping as influenced by the HIV/AIDS pandemic: A short history of the development of gating strategies for CD4+ T-cell enumeration. Cytometry 30, 157-165 (1997).
15. Stewart, C. C. & Steinkamp, J. A. Quantitation of cell concentration using the flow cytometer. Cytometry 2, 238-243 (1982).
16. Valet, G. A new method for fast blood cell counting and partial differentiation by flow cytometry. Blut 49, 83-90 (1984).
17. Connelly, M. C. et al. Standardization of absolute CD4+ lymphocyte counts across laboratories: An evaluation of the Ortho CytoronAbsolute flow cytometry system on normal donors. Cytometry 22, 200-210 (1995).
18. Mercolino, T. J. et al. Immunologic differentiation of absolute lymphocyte count with an integrated flow cytometric system: A new concept for absolute T cell subset determinations. Cytometry 22 48-59 (1995).
19. Reimann, K. A. et al. Multisite comparison of CD4 and CD8 T-lymphocyte counting by single- versus multiple-platform methodologies: evaluation of Beckman Coulter flow-count fluorospheres and the tetraONE system.The NIAID DAIDS New Technologies Evaluation Group. Clin. Diagn. Lab. Immunol. 7, 344-351 (2000).
20. Schnizlein-Bick, C. T., Spritzler, J., Wilkening, C. L., Nicholson, J. K. & O'Gorman, M. R. Evaluation of TruCount absolute-count tubes for determining CD4 and CD8 cell numbers in human immunodeficiency virus-positive adults. Site Investigators and The NIAID DAIDS New Technologies Evaluation Group. Clin. Diagn. Lab. Immunol. 7, 336-343 (2000).
21. Janossy, G., Jani, I. & Gohde, W. Affordable CD4(+) T-cell counts on 'single-platform' flow cytometers 1. Primary CD4 gating. Br. J. Haematol. 111, 1198-1208 (2000).
22. Glencross, D. K. et al. Large-scale affordable PanLeucogated CD4+ testing with proactive internal and external quality assessment: In support of the South African national comprehensive care, treatment and management programme for HIV and AIDS. Cytometry B Clin. Cytom. 74B (Suppl. 1), S40-S51 (2008).
23. Storie, I. et al. Flow rate calibration II: A clinical evaluation study using PanLeucoGating as a single-platform protocol. Cytometry 55, 8-13 (2003).
24. Barnett, D., Granger, V., Whitby, L., Storie, I. & Reilly, J. T. Absolute CD4+ T-lymphocyte and CD34+ stem cell counts by single-platform flow cytometry: The way forward. Br. J. Haematol. 106, 1059-1062 (1999).
25. Gratama, J. W., Kraan, J., Keeney, M., Granger, V. & Barnett, D. Reduction of variation in T-cell subset enumeration among 55 laboratories using single-platform, three or four-color flow cytometry based on CD45 and SSC-based gating of lymphocytes. Cytometry 50 92-101 (2002).
26. CLSI. Evaluation of precision performance of quantitative measurement methods. Approved guideline - second edition. NCCLS document EP5-A2 [online], http://www.clsi.org/source/orders/free/ep5-a2.pdf (CLSI, Wayne, Pennysylvania, USA, 2004).
27. Mandy, F. F., Nicholson, J. K. & McDougal, J. S. Guidelines for performing single-platform absolute CD4+ T-cell determinations with CD45 gating for persons infected with human immunodeficiency virus. Morbid. Mortal. Wkly Rep. 52, 1-13 (2003).
28. Barnett, D. et al. Guidelines for the enumeration of CD4+ T lymphocytes in immunosuppressed individuals. Clin. Lab. Haematol. 19, 231-241 (1997).
29. Mandy, F., Nicholson, J., Autran, B. & Janossy, G. T-cell subset counting and the fight against AIDS: Reflections over a 20-year struggle. Cytometry 50, 39-45 (2002).
30. Whitby, L. et al. Quality control of CD4+ T-lymphocyte enumeration: Results from the last 9 years of the United Kingdom National External Quality Assessment Scheme for Immune Monitoring (1993-2001). Cytometry 50, 102-110 (2002).
31. FDA. Food and Drugs Chapter 1 - Food and Drug Administration Department of Health and Human Services Subchapter H - Medical Devices Part 820 Quality System Regulation [online], http://www.accessdata.fda.gov/ scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?CFRPart=820 (FDA, Rockville, Maryland, USA, 2007).
32. Stevens, W. Good clinical laboratory practice (GCLP): The need for a hybrid of good laboratory practice and good clinical practice guidelines/ standards for medical testing laboratories conducting clinical trials in developing countries. Qual. Assur. 10, 83-89 (2003).
33. Banoo, S. et al. Evaluation of diagnostic tests for infectious diseases: General principles. Nature Rev. Microbiol. 4, S20-32 (2006).
34. Balakrishnan, P. et al. An inexpensive, simple, and manual method of CD4 T-cell quantitation in HIV-infected individuals for use in developing countries. J. Acquir. Immune Defic. Syndr. 36, 1006-1010 (2004).
35. Carella, A. V., Moss, M. W., Provost, V. & Quinn, T. C. A manual bead assay for the determination of absolute CD4+ and CD8+ lymphocyte counts in human immunodeficiency virus-infected individuals. Clin. Diagn. Lab. Immunol. 2, 623-625 (1995).
36. Diagbouga, S. et al. Successful implementation of a low-cost method for enumerating CD4+ T lymphocytes in resource-limited settings: the ANRS 12-26 study. AIDS 17, 2201-2208 (2003).
37. Didier, J. M. et al. Comparative assessment of five alternative methods for CD4+ T-lymphocyte enumeration for implementation in developing countries. J. Acquir. Immune Defic. Syndr. 26, 193-195 (2001).
38. Imade, G. E. et al. Comparison of a new, affordable flow cytometric method and the manual magnetic bead technique for CD4 T-lymphocyte counting in a northern nigerian setting. Clin. Diagn. Lab. Immunol. 12, 224-227 (2005).
39. Karcher, H., Bohning, D., Downing, R., Mashate, S. & Harms, G. Comparison of two alternative methods for CD4+ T-cell determination (Coulter manual CD4 count and CyFlow) against standard dual platform flow cytometry in Uganda. Cytometry B Clin. Cytom. 70B, 163-169 (2006).
40. Landay, A. et al. A rapid manual method for CD4+ T-cell quantitation for use in developing countries. AIDS 7, 1565-1568 (1993).
41. Lopez, A. et al. Enumeration of CD4(+) T-cells in the peripheral blood of HIV-infected patients: An interlaboratory study of the FACSCount system. Cytometry 38, 231-237 (1999).
42. Strauss, K. et al. Performance evaluation of the FACSCount System: a dedicated system for clinical cellular analysis. Cytometry 26 52-59 (1996).
43. Balakrishnan, P. et al. A reliable and inexpensive EasyCD4 assay for monitoring HIV-infected individuals in resource-limited settings. J. Acquir. Immune Defic. Syndr. 43, 23-26 (2006).
44. Pattanapanyasat, K. et al. Evaluation of a single-platform microcapillary flow cytometer for enumeration of absolute CD4+ T-lymphocyte counts in HIV-1 infected Thai patients. Cytometry B Clin. Cytom. 72B, 387-396 (2007).
45. Fryland, M. et al. The Partec CyFlow Counter could provide an option for CD4 + T-cell monitoring in the context of scaling-up antiretroviral treatment at the district level in Malawi. Trans. Roy. Soc. Trop. Med. Hyg. 100, 980-985 (2006).
46. Zijenah, L. S. et al. Affordable flow cytometry for enumeration of absolute CD4 + T-lymphocytes to identify subtype C HIV-1 infected adults requiring antiretroviral therapy (ART) and monitoring response to ART in a resource-limited setting. J. Transl. Med. 4, 33 (2006).
47. Dieye, T. N. et al. Evaluation of an affordable instrument for absolute CD4 counting in resource-poor setting against two reference clinical flow cytometers. Antivirol Ther. 8 (Suppl. 1) Abstract 1126 (2003).
48. Scott, L. E., Hansen, P., Glencross, D., K & Stevens, W. PointCARE CD4 testing: The new kid on the block, Abstract 742, session 126. 12th Conference on Retroviruses and Opportunistic infections (Boston, USA, 2005).
49. Glencross, D. K., Aggett, H. MW, Stevens, W. S. & Mandy, F. African regional external quality assessment for CD4 T-cell enumeration: development, outcomes, and performance of laboratories. Cytometry B Clin. Cytom. 740 (Suppl. 1), S69-79 (2008).
50. Bergeron, M., Houle, G., Azevedo, L., Grangerrio, A. & Mandy, F. F. The impact of single platform absolute counting technology with a linage specific marker and an external quality assessment program. Abstract B 12532, AIDS 2006 - XVI International AIDS Conference (Bangkok, Thailand, 2006).
51. Pattanapanyasat, K., Sukapirom, K., Kowawisatsut, L. & Thepthai, C. New BD FACSCount CD4 reagent system for simultaneous enumeration of percent and absolute CD4 T-lymphocytes in HIV-1-infected pediatric patients. Cytometry B Clin. Cytom. 74B (Suppl: 1) S98-106 (2008).
52. CLSI. User verification of performance for precision and trueness. Approved guideline - second edition. CLSI document EP15-A2 (CLSI, Wyne. Pennysylvania, USA, 2005).
53. International Organization for Standardization. Statistics - Vocabulary and symbols - Part 1: General statistical terms and terms used in probability (ISO-3534-1), (International Organization for Standardization, Geneva, Switzerland, 1993)
54. Denny, T. N. et al. NIAID-DAIDS Immunology Quality Assessment Program. A North American multilaboratory study of CD4 counts using flow cytometric panLeukogating (PLG): A NIAID-DAIDS Immunology Quality Assessment Program Study. Cytometry B Clin. Cytom.. 74B (Suppl. 1) S52-64 (2008).
55. Storie, I. et al. Perfect count: A novel approach for the single platform enumeration of absolute CD4+ T-lymphocytes. Cytometry B Clin. Cytom. 57, 47-52 (2004).
56. CLSI. Preliminary evaluation of quantitative clinical laboratory measurement procedures. Approved guideline - third edition. CLSI document EP10-A3 (CLSI, Wayne, Pennysylvania, USA, 2006).
57. Sokal, R. R & Braumann, C. A. Significance tests for coefficients of variation and variability profiles. Syst. Zool. 29, 50-66 (1980).
58. Haidane, J. B. S. The measurement of variation. Evolution 9, 484 (1955).
59. Mandy, F. Bergeron, M., Houle, G., Bradley. J, & Fahey, J. Impact of the international program for Quality Assessment and Standardization for Immunological Measures Relevant to HIV/AIDS: QASI. Cytometry 50 111-116 (2002).
60. Pattanapanyasat, K. et al. Thailand program for quality assessment and standardization for flow cytometric determination at CD4 T-lymphocyte counts for persons with HIV/AIDS. Abstract MoPeB3179. 15th International Conference on AIDS (Bangkok. Thailand, 2004).
61. Levey, S. & Jennings, E. R. The use of control charts in the clinical laboratory. Am. J. Clin. Pathol. 20, 1059-1066 (1950).
62. Brando, B. et al. Cytofluorometric methods for assessing absolute numbers of cell subsets in blood. European Working Group on Clinical Cell Analysis. Cytometry 42, 327-346 (2000).
63. Bergeron, M. et al. Stability of currently used cytometers facilitates the identification of pipetting errors and their volumetric operation: "time" can tell all. Cytometry B Clin. Cytom. 52 37-39 (2003).
64. Scott, L. E. & Glencross, D. K. Monitoring reproducibility of single analysis single platform CD4 cell counts in a high volume, low resource laboratory setting using sequential bead count rates. Cytometry B Clin. Cytom. 67, 31-32 (2005).
65. Coetzee, L. M., Scott, L. E., Lawrie, D., Glencross, D. K. & Stevens, W. Evaluation of pipetting methodology to assess precision and accuracy of single platform PLG CD4 enumeration. Abstract P32. 2nd South African AIDS Meeting (Durban, South Africa, 2005).
66. Bland, J. M. & Altman, D. G. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1, 307-310 (1986).
67. Scott, L. E. Galpin, J. S. & Glencross, D. K. Multiple method comparison: Statistical model using percentage similarity. Cytometry B Clin. Cytom. 54B, 46-53 (2003).
68. Pollock, M. A. et al. Method comparison - a different approach. Ann. Clin. Biochem. 29, 556-560 (1992).
69. Bossuyt, P. M. et al. Towards complete and accurate reporting of studies of diagnostic accuracy: The STARD initiative. Standards for Reporting of Diagnostic Accuracy. Clin. Chem. 49, 1-6 (2003).